Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Temgesic
Temgesic
Reckitt Benckiser buys back narcotic addition drug rights from Merck for $153 million
Yahoo/AP
Sun, 03/21/10 - 09:21 am
Reckitt Benckiser
Merck
narcotics
Suboxone
Subutex
Temgesic